A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Jiayi Huang, Jian L. Campian, Todd A. DeWees, Zdenek Skrott, Martin Mistrik, Tanner M. Johanns, George Ansstas, Omar Butt, Eric Leuthardt, Gavin P. Dunn, Gregory J. Zipfel, Joshua W. Osbun, Christopher Abraham, Shahed Badiyan, Katherine Schwetye, J. Gregory Cairncross, Joshua B. Rubin, Albert H. Kim, Milan G. Chheda

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science